Vaginal moniliasis in private practice.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003276:Contraceptives, Oral / Q000009:adverse effects; D003470:Culture Media; D005260:Female; D006801:Humans; D007223:Infant; D007434:Intrauterine Devices / Q000009:adverse effects; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010298:Parity; D014621:Vagina / Q000382:microbiology
D000935:Antifungal Agents; D003276:Contraceptives, Oral; D003470:Culture Media; D009761:Nystatin